Healthy Skepticism Library item: 6576

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

SmithKline Beecham claims Halfan is “effective in all types of malaria” and has an “excellent safety profile”
MaLAM International News 1995 Mar; 13:(3):1-2

Abstract:

SmithKline Beecham is promoting Halfan in Pakistan as a first-line therapy for malaria despite the fact that it is much more expensive than chloroquine and that chloroquine resistance is still very low.

Keywords:
*analysis/Pakistan/developing countries/SmithKline Beecham/Halfan/malaria/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES